Adverts

Open Access Articles- Top Results for Tucotuzumab celmoleukin

Tucotuzumab celmoleukin

</th></tr>
Tucotuzumab celmoleukin?
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target EpCAM
Clinical data
Identifiers
339986-90-2 7pxY
None
KEGG D09027 7pxY
Chemical data
Formula C7812H12124N2044O2408S60
175.1 kDa
 14pxY (what is this?)  (verify)

Tucotuzumab celmoleukin is an anti-cancer drug. It is a fusion protein of a humanized monoclonal antibody (tucotuzumab) and an interleukin-2 (celmoleukin).[1][2][3]

This drug was developed by EMD Pharmaceuticals.

References

  1. ^ Statement On A Nonproprietary Name Adopted By The Usan Council - Tucotuzumab Celmoleukin, American Medical Association.
  2. ^ ClinicalTrials.gov
  3. ^ National Cancer Institute: Definition of tucotuzumab celmoleukin


Lua error in package.lua at line 80: module 'Module:Buffer' not found. Lua error in package.lua at line 80: module 'Module:Buffer' not found.